Processa Pharmaceuticals
PCSA
PCSA
18 hedge funds and large institutions have $3.24M invested in Processa Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
SCM
1
Solas Capital Management
Darien,
Connecticut
|
$0 |
2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$4K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$0 |
4 |
4
BlackRock
New York
|
$81K |